A recent study’s results demonstrate that PuraCath Medical Inc.'s breakthrough UV-C device disinfects needleless connectors, potentially reducing CLABSI risks in hospital settings.
Poorly dressed central line catheter
(Adobe Stock 271083361 by Kiryl Lis)
Central line-associated bloodstream infections (CLABSIs) pose a significant threat to patient safety. Around 250,000 cases occur annually in the US alone, leading to high mortality and morbidity rates. In October 2020, the US Department of Health and Human Services (HHS) set ambitious targets to reduce health care-associated infections (HAIs), including a 50% reduction in CLABSIs by 2023.
A recent study, “Disinfection of Needleless Connectors for Catheters in One Second Using a Hand-Held UV Device,” published in the American Journal of Infection Control, explains that “inadequate disinfection of needleless connectors (NCs) of a [peripherally inserted central catheter] PICC or [central venous catheter] CVC can lead to CLABSIs.”
Historically, NCs have been disinfected using 70% isopropanol, chlorhexidine, or both, but they only clean external surfaces. Active scrubbing for 5 to 15 seconds is needed. Caps presaturated with disinfectant have been developed, but they do not disinfect intraluminal surfaces. Contamination of the NC intraluminal surface can cause CLABSIs and are prone to poor adherence; active scrubbing for 5 to 15 seconds is needed.
To address this challenge, PuraCath Medical Inc, has developed the Firefly UV Disinfection System, offering a novel approach to NC disinfection. The Firefly device's use of UV-transmissive cyclic-oleic copolymers allows for the disinfection of NCs' internal surfaces, addressing a crucial area of concern often overlooked by conventional disinfection methods. The handheld UV LED device is powered by a rechargeable lithium-ion battery.
The benchtop study, a strategy to reduce CLABSIs “showed that UV-C disinfection of UV-transmissive NCs using the Firefly device achieved over 4-log reduction in CFUs on the NC's external and internal surfaces,” according to the study’s authors. “The disinfection required 1 second of UV irradiation, in contrast to a 15-second alcohol scrub of nonalcohol-impregnated caps.”
The study explains a particular incentive: “In April 2009, the Centers for Medicare & Medicaid Services (CMS) stopped reimbursement for treatment of these [CLABSIs], except a suspension in 2020-2023 due to the COVID-19 pandemic. Between 2020 and 2021, CLABSI increased [by] 7% in US acute care hospitals, the largest increase observed in ICUs (10%).
In 2020, 30,100 reported CLABSIs occurred in ICUs and wards of US acute care facilities.” These numbers explain the financial incentive for hospitals and other health care facilities to push for reducing CLABSIs. The emotional and physical toll on the patients is incalculable.
Unlike traditional methods, the Firefly system utilizes UV-C light to disinfect both external and internal surfaces of NCs, effectively eliminating microbial contamination and reducing the risk of CLABSIs. The authors wrote, “A motivation to develop alcohol-containing caps was to improve [adherence] and minimize the opportunity for contaminant contact.”
The investigators evaluated NC disinfection with the Firefly system. They tested 22 samples with 5 relevant microbes to ensure 90% confidence and reliability using just 1 second of UV light exposure. CFU reduction was calculated by comparing pre- and post-UV-C exposure CFU counts.
With its potential to revolutionize NC disinfection practices, the Firefly UV Disinfection System offers hope in the battle against CLABSIs, providing a safer and more effective solution for health care facilities worldwide.
The study can be found here.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.